John D. Elliott

2.7k citations

66 papers · 1.9k indexed · h-index 26

Impact in

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Chemical Synthesis and Reactions
Biochemistry top 5%

Papers in

Organic Chemistry 28
- Asymmetric Synthesis and Catalysis 11
- Synthetic Organic Chemistry Methods 5
Endocrine and Autonomic Systems 6
- Neuroscience of respiration and sleep 6

Co-authors: William S. Johnson Eliot H. Ohlstein Paul A. Bartlett Stephen A. Douglas Derek H. R. Barton Stephen D. Géro Robert Ruffolo M. Amparo Lago
Journals: Tetrahedron Letters (11 papers)Journal of Cardiovascular Pharmacology (8 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of the Chemical Society Perkin Transactions 1 (4 papers)Journal of Medicinal Chemistry (4 papers)
Partner nations: United States China United Kingdom

In The Last Decade

John D. Elliott

66 papers receiving 1.7k citations

Peers

Countries citing papers authored by John D. Elliott

Since Specialization

Citations

This map shows the geographic impact of John D. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Elliott more than expected).

Fields of papers citing papers by John D. Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Elliott. The network helps show where John D. Elliott may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John D. Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John D. Elliott Line = papers co-authored together John D. Elliott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists Bioorganic & Medicinal Chemistry ·Yonghui Wang, Ting Yang, Qian Liu, Yingli Ma, Liuqing Yang, Ling Zhou, Zhijun Xiang, Ziqiang Cheng, Sijie Lu, Lisa A. Orband‐Miller, Wei Zhang, Qianqian Wu, J.M Kunst, Yi Li, Jia‐Ning Xiang, John D. Elliott, Stewart Leung, Feng Ren, Xichen Lin	2015	26
2	2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·Atlas Of Living Australia, Ting Yang, Gaspar Sánchez Salas, Paul Wren, Yueting Zhang, Xin Cai, 公益関, Kelly Dong, Qing Zhang, Wei Zhang, Xiao-Ming Guan, Jia‐Ning Xiang, John D. Elliott, Xichen Lin, Feng Ren	2014	11
3	Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors Bioorganic & Medicinal Chemistry ·Guanghui Deng, Baowei Zhao, Yingli Ma, 謙一小柳, Hailong Wang, Liuqing Yang, Qing Zhang, Taylor B. Guo, Wei Zhang, Vojtěch Špatný, Xin Cai, Jinqiang Zhang, Houfu Liu, Xiao-Ming Guan, Hongtao Lu, Jia‐Ning Xiang, John D. Elliott, Xichen Lin, Feng Ren	2013	14
4	Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists Bioorganic & Medicinal Chemistry Letters ·Carlos Alberto Fruet Filho, Baowei Zhao, 謙一小柳, Xuesong Xu, Guanghui Deng, Chengyong Li, Yu Fan, Feng Ren, Hailong Wang, Heng Xu, Yan Xu, Haibo Zhang, Jia‐Ning Xiang, John D. Elliott, Taylor B. Guo, Yonggang Zhao, Wei Zhang, Hongtao Lu, Xichen Lin	2012	14
5	N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors Bioorganic & Medicinal Chemistry Letters ·Hong Nie, Katherine L. Widdowson, Michael R. Palovich, Г О Арипжанова, John D. Elliott, Deborah Bryan, Miriam Burman, Dulcie B. Schmidt, James J. Foley, Henry M. Sarau, Jakob Busch‐Petersen	2006	21
6	New Strategies in Drug Discovery Humana Press eBooks ·Eliot H. Ohlstein, Anthony G. Johnson, John D. Elliott, Anne M. Romanic	2006	4
7	Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor Bioorganic & Medicinal Chemistry Letters ·Qi Jin, Hong Nie, M.A.T. de Silva, Katherine L. Widdowson, Michael R. Palovich, John D. Elliott, Gillian Lawrence, Miriam Burman, Henry M. Sarau, Keith W. Ward, 苏如国, Harshal Chikhale, Peter D. Gorycki, Jakob Busch‐Petersen	2004	32
8	Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity Pharmaceutical Research ·Patric Stenberg, Kristina Luthman, Harma Ellens, Anthony Bärlocher Miller, Philip L. Smith, Amparo M. Lago, John D. Elliott, Per Artursson	1999	43
9	Trigeminal nerve ganglion stimulation‐induced neurovascular reflexes in the anaesthetized cat: Role of endothelin_B receptors in carotid vasodilatation British Journal of Pharmacology ·Pravin Raval, Sharon Bingham, Nambi Aiyar, John D. Elliott, Andrea Hunter, Eliot H. Ohlstein, Andrew A. Parsons	1999	11
10	SB 234551, a Novel Endothelin-A Receptor Antagonist, Unmasks Endothelin-Induced Renal Vasodilatation in the Dog Journal of Cardiovascular Pharmacology ·David P. Brooks, Vail Andy, Mark Pullen, John D. Elliott, Eliot H. Ohlstein, Ponnal Nambi	1998	13
11	Pharmacologic Characterization of the Novel, Orally Available Endothelin-A-Selective Antagonist SB 247083 Journal of Cardiovascular Pharmacology ·Stephen A. Douglas, Ponnal Nambi, Miklos Gellai, Juan I. Luengo, Jia‐Ning Xiang, David P. Brooks, Robert Ruffolo, John D. Elliott, Eliot H. Ohlstein	1998	5
12	Plasma- and Cerebrospinal Fluid-Immunoreactive Endothelin-1: Effects of Nonpeptide Endothelin Receptor Antagonists with Diverse Affinity Profiles for Endothelin-A and Endothelin-B Receptors Journal of Cardiovascular Pharmacology ·Robert N. Willette, Charles F. Sauermelch, Barbara L. Storer, Shinta Adella, Juan I. Luengo, Jia‐Ning Xiang, John D. Elliott, Eliot H. Ohlstein	1998	18
13	An Efficient Approach to the Synthesis of 1,3-Diaryl-1,2,3,4-[4H]-tetrahydronaphthalene-2-carboxylic Acids Bioorganic & Medicinal Chemistry ·Jia‐Ning Xiang, Ponnal Nambi, Eliot H. Ohlstein, John D. Elliott	1998	10
14	Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon Biochemical and Biophysical Research Communications ·Paul M. Keller, Chao‐Pin Lee, Ashley Fenwick, K Tirupathi, John D. Elliott, Walter E. DeWolf	1996	16
15	Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein British Journal of Pharmacology ·Stephen A. Douglas, George R. Beck, John D. Elliott, Eliot H. Ohlstein	1995	43
16	In vivo pharmacological characterization of the non‐peptide endothelin receptor antagonist SB 209670 British Journal of Pharmacology ·Stephen A. Douglas, Richard M. Edwards, John D. Elliott, Eliot H. Ohlstein	1995	17
17	Pharmacologic Evidence for the Presence of Three Functional Endothelin Receptor Subtypes in Rabbit Saphenous Vein Journal of Cardiovascular Pharmacology ·Stephen A. Douglas, George R. Beck, John D. Elliott, Eliot H. Ohlstein	1995	19
18	1,3-Diarylindan-2-carboxylic Acids, Potent and Selective Non-Peptide Endothelin Receptor Antagonists Journal of Medicinal Chemistry ·John D. Elliott, M. Amparo Lago, Russell D. Cousins, 美広柳原, Jack D. Leber, Karl F. Erhard, P Nambi, Nabil A. Elshourbagy, Chandrika Kumar	1994	105
19	Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase Biochemistry ·Pearl Louis-Flamberg, Catherine E. Peishoff, Deborah Bryan, Jack D. Leber, John D. Elliott, Brian W. Metcalf, Ruth J. Mayer	1990	11
20	Asymmetric synthesis via acetal templates. 13. Preparation of aldol compounds from butane-1,3-diol acetals The Journal of Organic Chemistry ·I. Silverman, Jay M Minorik, John D. Elliott, William S. Johnson	1987	37

About John D. Elliott

John D. Elliott is a scholar working on Organic Chemistry, Endocrine and Autonomic Systems, Physiology, Biochemistry and Spectroscopy, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (20 papers), Asymmetric Synthesis and Catalysis (11 papers), Receptor Mechanisms and Signaling (8 papers), Chemical Synthesis and Analysis (7 papers), Neuroscience of respiration and sleep (6 papers), Renin-Angiotensin System Studies (6 papers), Analytical Chemistry and Chromatography (5 papers) and Synthetic Organic Chemistry Methods (5 papers). The work is most often cited by research in Organic Chemistry (840 citations), Biochemistry (151 citations), Physiology (491 citations), Cardiology and Cardiovascular Medicine (246 citations) and Pharmaceutical Science (63 citations). John D. Elliott has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include William S. Johnson, Eliot H. Ohlstein, Paul A. Bartlett, Stephen A. Douglas, Derek H. R. Barton, Stephen D. Géro, Robert Ruffolo, M. Amparo Lago, Anthony J. Arleth and Jack D. Leber. Their work appears in journals such as Tetrahedron Letters, Journal of Cardiovascular Pharmacology, Bioorganic & Medicinal Chemistry Letters, Journal of the Chemical Society Perkin Transactions 1 and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact